126 related articles for article (PubMed ID: 38086492)
1. Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients.
Ogadah CU; Mrštná K; Matysová L; Müllertz A; Rades T; Niederquell A; Šklubalová Z; Vraníková B
Int J Pharm; 2024 Jan; 650():123702. PubMed ID: 38086492
[TBL] [Abstract][Full Text] [Related]
2. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
Grobelny P; Kazakevich I; Zhang D; Bogner R
Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
[TBL] [Abstract][Full Text] [Related]
4. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
[TBL] [Abstract][Full Text] [Related]
5. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac.
Vadher AH; Parikh JR; Parikh RH; Solanki AB
AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620
[TBL] [Abstract][Full Text] [Related]
7. The importance of the coating material type and amount in the preparation of liquisolid systems based on magnesium aluminometasilicate carrier.
Vraníková B; Svačinová P; Marushka J; Brokešová J; Holas O; Tebbens JD; Šklubalová Z
Eur J Pharm Sci; 2021 Oct; 165():105952. PubMed ID: 34298140
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
9. Functionalised calcium carbonate as a coformer to stabilize amorphous drugs by mechanochemical activation.
Liu J; Rades T; Tho I; Kissi EO
Eur J Pharm Biopharm; 2020 Oct; 155():22-28. PubMed ID: 32768607
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
11. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
[TBL] [Abstract][Full Text] [Related]
12. Porous calcium carbonate as a carrier material to increase the dissolution rate of poorly soluble flavouring compounds.
Lundin Johnson M; Noreland D; Gane P; Schoelkopf J; Ridgway C; Millqvist Fureby A
Food Funct; 2017 Apr; 8(4):1627-1640. PubMed ID: 28295108
[TBL] [Abstract][Full Text] [Related]
13. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
14. OPTIMIZATION OF FUROSEMIDE LIQUISOLID TABLETS PREPARATION PROCESS LEADING TO THEIR MASS AND SIZE REDUCTION.
Kurek M; Woyna-Orlewicz K; Khalid MH; Jachowicz R
Acta Pol Pharm; 2016 Sep; 73(5):1325-1331. PubMed ID: 29638072
[TBL] [Abstract][Full Text] [Related]
15. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
16. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
Kamble PR; Shaikh KS; Chaudhari PD
Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
[TBL] [Abstract][Full Text] [Related]
17. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
18. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
20. Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation.
Vraníková B; Gajdziok J; Vetchý D
Pharm Dev Technol; 2015 Nov; 20(7):839-844. PubMed ID: 24927105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
